Sublingual apomorphine for Parkinsonian tremor: a post-hoc analysis of pivotal trial data.
Early findings suggest a liquid form of Parkinson's medication may improve tremor better than standard oral treatments.
Tremor is a common and disabling feature of Parkinson's disease (PD) and often responds suboptimally to oral dopaminergic therapy. These exploratory findings in a small subgroup are consistent with a potential for early and maintained tremor improvement with SL‑APO in patients with tremor‑dominant PD; however, the results are hypothesis‑generating a...
What the study was
- Study design
- Randomized study
- Population
- patients
- Sample size
- 10
- Category
- Other
- Maturity
- Exploratory
- Journal
- Journal of neural transmission (Vienna, Austria : 1996)
Why it surfaced
Score 6/10 [PROMISING_PRELIMINARY]: Randomized study (Journal Article) matched 'Hematologic malignancies (AML, MDS, CLL,'. Components — novelty:1/3, relevance:2/3, design:2/2, population:1/2. Confidence: high. Conservative scoring applied per v1.3 rubric.
A plain-language summary of published research — not medical advice. Talk to a clinician about your own care.